关注
Dinuka Ariyaratne
Dinuka Ariyaratne
Clinical Database Manager
在 Petermac.org 的电子邮件经过验证
标题
引用次数
引用次数
年份
ExoCarta: a web-based compendium of exosomal cargo
S Keerthikumar, D Chisanga, D Ariyaratne, H Al Saffar, S Anand, K Zhao, ...
Journal of molecular biology 428 (4), 688-692, 2016
13292016
Colorectal cancer atlas: an integrative resource for genomic and proteomic annotations from colorectal cancer cell lines and tissues
D Chisanga, S Keerthikumar, M Pathan, D Ariyaratne, H Kalra, ...
Nucleic acids research 44 (D1), D969-D974, 2016
562016
The genomic and immune landscape of long-term survivors of high-grade serous ovarian cancer
DW Garsed, A Pandey, S Fereday, CJ Kennedy, K Takahashi, K Alsop, ...
Nature genetics 54 (12), 1853-1864, 2022
382022
TRACEBACK: testing of historical tubo-ovarian cancer patients for hereditary risk genes as a cancer prevention strategy in family members
R Delahunty, L Nguyen, S Craig, B Creighton, D Ariyaratne, DW Garsed, ...
Journal of Clinical Oncology 40 (18), 2036-2047, 2022
62022
Contrasting clinical characteristics and treatment patterns in women with newly diagnosed advanced-stage epithelial ovarian cancer in Australia, South Korea and Taiwan
HH Chou, S Fereday, A DeFazio, CL Chang, D Bowtell, HC Hsu, ...
Journal of Gynecologic Oncology 34 (1), 2023
22023
# 71 Integrated multi-omic and clinicopathological analysis of high-grade serous ovarian cancer in BRCA1/2 mutated patients with poor survival: identification of predictive …
TA Zwimpfer, S Fereday, A Pandey, L Twomey, D Ariyaratne, EL Goode, ...
International Journal of Gynecologic Cancer 33 (Suppl 3), 2023
12023
# 70 Influence of predictive features on therapy response and survival in high-grade serous ovarian cancer patients by germline BRCA mutation status: an update from the …
TA Zwimpfer, S Fereday, D Ariyaratne, L Twomey, N Traficante, EL Goode, ...
International Journal of Gynecologic Cancer 33 (Suppl 3), 2023
12023
Concurrent RB1 Loss and BRCA-Deficiency Predicts Enhanced Immunological Response and Long-Term Survival in Tubo-Ovarian High-Grade Serous Carcinoma
FAM Saner, K Takahashi, T Budden, A Pandey, D Ariyaratne, ...
Clinical Cancer Research, 2024
2024
Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma
C Wang, MS Block, JM Cunningham, ME Sherman, BM McCauley, ...
Cancer Epidemiology, Biomarkers & Prevention 32 (4), 542-549, 2023
2023
Bioinformatics analysis of OMICs data
MU Pathan
La Trobe, 2019
2019
Protein networks in colorectal cancer cells
D Chisanga
La Trobe University, 2017
2017
系统目前无法执行此操作,请稍后再试。
文章 1–11